Maxim Boosts Healthcare Initiatives With Biosensor Module
Zacks Investment Research | Jan 09, 2019 09:17PM ET
Maxim Integrated Products, Inc. (NASDAQ:MXIM) is leaving no stone unturned to expand footprint in the healthcare sector on the back of its robust sensors.
The company has unveiled a biosensor module called MAX86150 that is capable of offering accurate photoplethysmogram (PPG) and electrocardiogram (ECG) measurements via mobile phones, laptops, tablets and smart speakers.
Notably, the senor is FDA certified and the first-of-its kind in the analog and mixed-signal industry. Further, the latest launch broadens the company’s key offerings and is likely to boost business growth.
Further, sensor is expected to enable the company gain traction among customers demanding for health monitoring devices.
Coming to the price performance, shares of Maxim have lost 6.2% in the past year compared with the Maxim Integrated Products, Inc. Quote
Growing Healthcare Initiatives
The company’s recent move is likely to enhance healthcare initiatives.
Apart from MAX86150, Maxim has recently introduced MAX20345 that is an ultra-low-power integrated power-management IC (PMIC). The system will offer accurate measurement for optical-sensitivity in wearables and other health applications.
Further, the company’s first wrist-worn platform named — Health Sensor Platform 2.0 —is expected to provide various health parameters to the wearable designers and health application developers by monitoring the electrocardiogram (ECG), heart rate and body temperature of an individual.
Also, the company’s wearable platforms — MAX-HEALTH-BAND and MAX-ECG-MONITOR —are fortifying its position in the booming wearable market.
We believe that the above mentioned endeavors will continue to drive the company’s performance in the consumer market.
Zacks Rank & Stock to Consider
Currently, Maxim carries Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader technology sector are Marvell Technology Group (NASDAQ:MRVL) , Infineon Technologies (OTC:IFNNY) and Lattice Semiconductor (NASDAQ:LSCC) . While Marvell Technology and Infineon Technologies sport a Zacks Rank #1 (Strong Buy), Lattice Semiconductor carries a Zacks Rank #2 (Buy). You can see Zacks Investment Research
Get The News You Want